Two cancer research studies demonstrate use of RNA sequencing for precision oncology

November 24, 2021 Leave a comment 1,546 Views

Genetron Health announced the release of two research results from its Seq-MRD® and FusionScan Plus product studies at the Association for Molecular Pathology 2021 annual meeting. Seq-MRD® detects minimal residual disease (MRD) in B-lymphoid malignancies, while FusionScan Plus can simultaneously detect a wide ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Seq-MRD

Two cancer research studies demonstrate use of RNA sequencing for precision oncology

GiRAFR – gRNA detection and annotation in single-cell CRISPR screens

RNA sequencing reaveals novel intracellular signaling mechanisms that promote melanoma growth

AAV-Perturb-seq – adeno-associated virus (AAV)-mediated direct in vivo single-cell CRISPR screening

capTEs – Cas9-assisted profiling transposable elements expression sequencing

eSPET-seq – genome-wide probing of eukaryotic nascent RNA structure

DISCERN – deep single-cell expression reconstruction for improved cell clustering and cell subtype and state detection

Advancements in genome sequencing propel global RNA sequencing market growth to 2030